FundedIQ
Biotechnology

Dash Bio: Funding, Investors & Team (Oct 2026)

Dash Bio is a cutting-edge platform that employs AI, robotics, and fully integrated software to revolutionize the process of drug development and bring new medications to market.

www.dash.bio LinkedIn Boston, United States 11-50 employees Founded 2024
Total raised
$47.5M
Rounds
3
Latest
Series A
Aug 2026

Dash Bio has raised $47.5M across 3 funding rounds on record, the most recent a Series A of $30.0M announced in Aug 2026.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Dash Bio Company Profile and Key Stats

Total funding raised
$47.5M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Series A
$30.0M in Aug 2026
Employees
11-50
reported band
Founded
2024
Headquarters
Boston, United States
Investors on record
11
5 named below

Latest funding round on record: Aug 2026.

Dash Bio Funding Rounds

Date
Round
Amount
Series A
$30.0M
Seed
$11.0M
Seed
$6.5M

Dash Bio raised $6.5M in a Seed announced in Oct 2024.

9 months later, a Seed of $11.0M was announced in Jul 2025.

1.1 years later, a Series A of $30.0M was announced in Aug 2026.

Dash Bio Investors

Oak HC/FT Freestyle Capital Swift Ventures LifeX Ventures Cybernetix Ventures

11 investors are recorded in total; the 5 named above are those the record identifies.

Dash Bio Founders and Leadership Team

Name
Role
Contact
Ander Tallett
Co-Founder & COO
Locked
Dave Johnson
Founder
Locked

Contact details for the Dash Bio team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

Dash Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
8,591
$15M

Dash Bio's latest round of $30.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Dash Bio in Biotechnology and Boston

Companies Similar to Dash Bio

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Dash Bio Funding FAQs

What does Dash Bio do?

Dash Bio is a cutting-edge platform that employs AI, robotics, and fully integrated software to revolutionize the process of drug development and bring new medications to market.

How much funding has Dash Bio raised?

Dash Bio has raised $47.5M across 3 rounds on record. The most recent is a Series A of $30.0M announced in Aug 2026.

When did Dash Bio last raise funding?

Dash Bio's most recent funding round on record is a Series A of $30.0M, announced in Aug 2026.

Who has invested in Dash Bio?

Investors on record for Dash Bio include Oak HC/FT, Freestyle Capital, Swift Ventures, LifeX Ventures, Cybernetix Ventures. FundedIQ records 11 investors in total.

Who founded Dash Bio?

FundedIQ lists Ander Tallett (Co-Founder & COO), Dave Johnson (Founder) at Dash Bio.

Where is Dash Bio headquartered?

Dash Bio is based in Boston, Massachusetts, United States.

How many employees does Dash Bio have?

Dash Bio is in the 11-50 employee band.

When was Dash Bio founded?

Dash Bio was founded in 2024.

How does Dash Bio's funding compare to other Biotechnology startups?

Dash Bio's latest round of $30.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Dash Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Dash Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.